Lecanemab, a drug designed to slow the progression of early stage Alzheimer's will not be available to patients in Sweden for ...
A landmark study examining over 3.4 million brain cells has revealed that Alzheimer’s disease progresses through two distinct ...
In a new era of Alzheimer’s disease research, the emergence of blockbuster therapies like Eli Lilly’s Kisunla (donanemab) and ...
A quick finger prick and a few drops of blood on a card that can be sent in regular mail. This approach could soon make ...